Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Apricus Biosciences Inc (NASDAQ:APRI)

During the Trading Day
1.76 +0.15 / +9.32%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
1.77 +0.01 / +0.57%
 
Volume: 200.00

Today’s Trading

Previous close1.61
Today’s open1.60
Day’s range1.49 - 1.76
Volume282,018
Average volume (3 months)201,363
Market cap$81.2M
Dividend yield--
Data as of 3:59pm ET, 09/04/2015

Growth & Valuation

Earnings growth (last year)-20.30%
Earnings growth (this year)+21.21%
Earnings growth (next 5 years)--
Revenue growth (last year)+268.74%
P/E ratioNM
Price/Sales4.27
Price/Book37.19

Competitors

 Today’s
change
Today’s
% change
PULMPulmatrix Inc-0.05-0.90%
VTLVital Therapies Inc-0.09-2.61%
CTRVContraVir Pharmaceut...-0.06-1.72%
MSTXMast Therapeutics In...-0.00-0.21%
Data as of 4:01pm ET, 09/04/2015

Financials

Next reporting dateNovember 17, 2015
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$9.3M
Annual profit (last year)-$21.8M
Net profit margin-242.76%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer, Secretary &
Director
Richard W. Pascoe
Chief Accounting Officer &
Vice President-Finance
Catherine Bovenizer
Corporate headquarters
San Diego, California

Forecasts

Partner Offers